Omeros
Biotech companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
- Complete response letters: 1
- Drug applications: 1
Records by Year
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
Latest Records
Newest first across sources; each opens the record| Date | Record | Source |
|---|---|---|
| Oct 15, 2021 | Complete response letter, BLA 761152Approved | Complete response letters |
Cash Runway
From SEC filings; a rough screen, not a forecast- Cash and investments, Jun 30, 2026
- $132M
- Operating cash burn, 2025
- $116M
- Runway at that burn
- 14 months
- SEC filings
- CIK 1285819
Names and Identifiers
- Appears as
- Website
- omeros.com
- Wikidata
- Q30284118
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built